Microbot Medical Inc.
Microbot Medical Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 3 | 4 | 4 | 7 | 4 | 3 | 3 | 0 | 2 | 1 | 2 | 1 | |||||
Assets Current | |||||||||||||||||
Assets Current | 72 | 77 | 80 | 81 | 33 | 31 | 6 | 5 | 7 | 7 | 8 | 8 | |||||
Marketable Securities Current | 64 | 69 | 75 | 73 | 29 | 27 | 2 | 4 | 4 | 5 | 4 | 7 | |||||
Restricted Cash And Cash Equivalents At Carrying V… | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Assets Current | - | - | - | - | - | - | - | - | - | - | 1 | - | |||||
Deposits Assets Current | 1 | 1 | - | - | - | - | - | - | - | - | - | - | |||||
Accounts Receivable Net Current | 0 | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Inventory Net | 3 | 2 | 1 | - | - | - | - | - | - | - | - | - | |||||
Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | |||||
Assets Noncurrent | |||||||||||||||||
Restricted Cash And Cash Equivalents Noncurrent | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | |||||
Deposit Assets | - | - | 1 | - | - | - | - | - | - | - | - | - | |||||
Deposits Assets Noncurrent | 0 | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accounts Payable Trade Current | - | - | - | - | - | - | 0 | - | - | - | 0 | - | |||||
Assets | 73 | 78 | 82 | 82 | 33 | 31 | 6 | 5 | 7 | 7 | 8 | 9 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Accounts Payable Current | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | - | 0 | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | |||||||||||||||||
Liabilities Current | 4 | 3 | 3 | 3 | 3 | 2 | 2 | 1 | 1 | 1 | 4 | 1 | |||||
Litigation Reserve Current | - | - | - | - | - | - | - | - | - | - | 2 | - | |||||
Accrued Liabilities Current | 3 | 2 | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | |||||
Liabilities Noncurrent | |||||||||||||||||
Operating Lease Liability Noncurrent | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 4 | 4 | 4 | 4 | 3 | 2 | 3 | 1 | 1 | 1 | 4 | 2 | |||||
Common Stock Value | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 182 | 181 | 181 | 178 | 127 | 122 | 94 | 91 | 90 | 88 | 84 | 84 | |||||
Stockholders Equity | |||||||||||||||||
Stockholders Equity | 69 | 74 | 78 | 78 | 30 | 29 | 4 | 4 | 6 | 6 | 5 | 7 | |||||
Retained Earnings Accumulated Deficit | -113 | -108 | -104 | -101 | -97 | -94 | -91 | -88 | -84 | -82 | -80 | -76 | |||||
Liabilities And Stockholders Equity | 73 | 78 | 82 | 82 | 33 | 31 | 6 | 5 | 7 | 7 | 8 | 9 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 120 | 120 | 120 | 120 | 120 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | |||||
Common Stock Shares Issued | 67 | 67 | 67 | 66 | 38 | 35 | 19 | 17 | 16 | 14 | 12 | 12 | |||||
Shares Outstanding | 67 | 67 | 67 | 66 | 38 | 35 | 19 | 17 | 16 | 14 | 12 | 12 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -15.21% | -11.98% | -20.74% | - | - | - | - | - | - | - | - | - |
| 2025 | 14.23% | 5.69% | 3.66% | 17.31% | -1.60% | -28.53% | 11.79% | -0.47% | -15.09% | -10.69% | -29.39% | -32.06% |
| 2024 | 16.13% | 15.05% | -1.08% | -11.11% | -9.09% | -4.04% | -2.00% | 114.00% | 84.00% | 56.60% | 68.55% | 47.17% |
| 2023 | - | - | - | -1.92% | -34.13% | -31.73% | -10.07% | -0.72% | -12.95% | -24.35% | -18.26% | -6.09% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 18.56 | 22.59 | 23.33 | 27.53 | 12.06 | 16.19 | 2.37 | 3.64 | 5.32 | 5.92 | 2.09 | 5.64 | |||||
| Quick Ratio | 17.63 | 21.73 | 22.97 | 27.34 | 12.00 | 16.08 | 2.24 | 3.20 | 4.85 | 5.41 | 2.05 | 5.50 | |||||
| Working Capital | 68.29M | 73.14M | 76.40M | 77.85M | 30.16M | 28.76M | 3.36M | 3.62M | 5.80M | 5.82M | 4.14M | 6.92M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.06 | 0.05 | 0.05 | 0.05 | 0.09 | 0.07 | 0.71 | 0.37 | 0.23 | 0.19 | 0.85 | 0.21 | |||||
| Interest Coverage TTM | -8.54 | -8.77 | -11.47 | -21.63 | -29.94 | -44.92 | -63.87 | -60.02 | -51.67 | -53.26 | -43.22 | -39.33 | |||||
| Debt Ratio | 0.06 | 0.05 | 0.05 | 0.04 | 0.08 | 0.06 | 0.41 | 0.27 | 0.19 | 0.16 | 0.46 | 0.17 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Days Sales Outstanding TTM | 185.66 | 365.00 | - | - | - | - | - | - | - | - | - | - | |||||
| Receivables Turnover TTM | 1.97 | 1.00 | - | - | - | - | - | - | - | - | - | - | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.24 | -0.21 | -0.29 | -0.27 | -0.35 | -0.38 | -0.73 | -0.68 | -0.70 | -0.73 | -1.05 | -0.90 | |||||
| Free Cash Flow Per Share TTM | -0.27 | -0.23 | -0.29 | -0.23 | -0.27 | -0.30 | -0.57 | -0.55 | -0.53 | -0.56 | -0.84 | -0.79 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Operating Profit Margin TTM | -5,348.84% | -15,278.10% | - | - | - | - | - | - | - | - | - | - | |||||
| Net Profit Margin TTM | -4,722.25% | -13,535.24% | - | - | - | - | - | - | - | - | - | - | |||||
Growth Metrics | |||||||||||||||||
| Net Income Growth (1Y) | 28.57% | 21.75% | 14.85% | 16.64% | 21.77% | 13.79% | 6.55% | 5.87% | -10.08% | -20.06% | -18.44% | -24.56% | |||||
| EPS Growth (1Y) | -30.15% | -43.64% | -60.76% | -60.05% | -50.45% | -48.55% | -30.53% | -24.75% | -44.29% | -54.43% | -41.94% | -54.19% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -8.02 | -11.39 | -6.97 | -11.22 | -7.24 | -4.02 | -1.53 | -1.31 | -1.45 | -1.69 | -1.56 | -1.54 | |||||
| P/B TTM | 1.90 | 2.18 | 1.18 | 1.88 | 3.03 | 1.62 | 4.96 | 3.85 | 2.50 | 2.80 | 3.72 | 2.21 | |||||
| P/S TTM | 378.52 | 1,541.44 | - | - | - | - | - | - | - | - | - | - | |||||
| Market Cap | 130.97M | 161.85M | 91.58M | 146.69M | 91.95M | 46.94M | 17.52M | 14.66M | 15.14M | 17.29M | 16.73M | 16.27M | |||||
| Enterprise Value | 127.82M | 158.19M | 87.67M | 139.93M | 87.81M | 43.72M | 14.41M | 14.13M | 12.63M | 16.13M | 14.26M | 14.94M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -17.93M | -15.38M | -13.11M | -11.02M | -9.93M | -9.31M | -8.85M | -8.98M | -7.90M | -7.81M | -8.58M | -9.21M | |||||
| Net Debt | -3.15M | -3.66M | -3.91M | -6.76M | -4.14M | -3.22M | -3.11M | -527.00K | -2.51M | -1.16M | -2.47M | -1.34M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Microbot Medical Inc. (MBOT) — SEC Financial Statements & Analysis
Microbot Medical Inc. (MBOT) is a surgical & medical instruments & apparatus company, incorporated in DE. Microbot Medical Inc. trades on Nasdaq as: MBOT. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Microbot Medical Inc. reported a Debt-to-Equity ratio of 0.06x, a Price-to-Sales (P/S) ratio of 378.52x (TTM), a Price-to-Book (P/B) ratio of 1.90x (TTM), at a market cap of $130.97M. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- 0.06x
- P/S TTM
- 378.52x
- P/B TTM
- 1.90x
- Market Cap
- $130.97M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Microbot Medical Inc. in?
Microbot Medical Inc. (MBOT) operates in the Surgical & Medical Instruments & Apparatus industry.
What is MBOT's market cap?
Microbot Medical Inc. (MBOT) has a market capitalization of $130.97M as of 2026-06-30.
What exchange does MBOT trade on?
Microbot Medical Inc. (MBOT) trades on the Nasdaq.
Where is Microbot Medical Inc. incorporated?
Microbot Medical Inc. is incorporated in DE.